Herbert Irving Comprehensive Cancer Center

      

    

    

      

        


                Flash Section

        

        
HICCC

      

      

      

            








        












  

        
Welcome to the Cancer Center's clinical trials online search tool. Clinical trials are studies designed to test the effectiveness of new treatments, including new drugs or new combinations of drugs. For additional information about these trials, call the Cancer Center's Clinical Research Management Office at (212) 305-8615.


    

        

        

            
Study ID Search

            
            
        

        

        
    


    

        
Advanced Search Form

        

        

            Group(s)
            
			 			 Adults
							 			     Pediatrics
				            
            
                
            
        

        

            
             
        

        

            

        
        

        

        
    




   
2 Results

           


            
Other Skin


            
ID:AAAB2309


                
 Externally Peer Reviewed

                Principal Investigator: Dr. Joseph Graziano


            

                Adult:

                Chemoprevention of arsenic-induced skin cancer            



            

                This is a study to evaluate two agents, selenium and vitamin E, in the prevention of skin cancer in people who have been exposed to high levels of arsenic.  People in Bangladesh who have skin rashes caused by arsenic are at a high risk of developing skin cancer, and will be assigned to one of four treatment arms, that include a combination of selenium, Vitamin E, or a placebo.  Participants will be treated for five years, and will undergo regular physical exams focusing on skin exams as well as blood tests at 4 occasions looking at levels of the drugs.  The goal is to determine whether either or both of these agents can decrease the risk of skin cancer in people exposed to high levels of arsenic.;				  


            
For more information and to inquire about eligibility for this study, please contact the Cancer Center office at 212-305-8615.

                   



        


            
Other Skin


            
ID:AAAJ8554


                
 Institutional

                Principal Investigator: Dr. David Bickers


            

                Adult:

                A PHASE II RANDOMIZED, OPEN LABEL TRIAL COMPARING THE EFFECTS OF INTERMITTENT VISMODEGIB VS. PHOTODYNAMIC THERAPY ON THE MAINTENANCE OF BENEFIT FOLLOWING 7 MONTHS OF CONTINUOUS VISMODEGIB TREATMENT IN PATIENTS WITH MULTIPLE BASAL CELL CARCINOMAS            



            

                 Please click here to view more information in ClinicalTrials.gov.				  


            
For more information and to inquire about eligibility for this study, please contact the Cancer Center office at 212-305-8615.

                   









  


  

    

        


       

  












                

                

            


	      


  
 bottom